1. Home
  2. STOK vs HBNC Comparison

STOK vs HBNC Comparison

Compare STOK & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • HBNC
  • Stock Information
  • Founded
  • STOK 2014
  • HBNC 1873
  • Country
  • STOK United States
  • HBNC United States
  • Employees
  • STOK N/A
  • HBNC 876
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • HBNC Major Banks
  • Sector
  • STOK Health Care
  • HBNC Finance
  • Exchange
  • STOK Nasdaq
  • HBNC Nasdaq
  • Market Cap
  • STOK 721.4M
  • HBNC 692.0M
  • IPO Year
  • STOK 2019
  • HBNC N/A
  • Fundamental
  • Price
  • STOK $9.36
  • HBNC $15.83
  • Analyst Decision
  • STOK Strong Buy
  • HBNC Hold
  • Analyst Count
  • STOK 8
  • HBNC 2
  • Target Price
  • STOK $21.83
  • HBNC $18.50
  • AVG Volume (30 Days)
  • STOK 933.4K
  • HBNC 165.3K
  • Earning Date
  • STOK 11-05-2024
  • HBNC 01-22-2025
  • Dividend Yield
  • STOK N/A
  • HBNC 4.04%
  • EPS Growth
  • STOK N/A
  • HBNC N/A
  • EPS
  • STOK N/A
  • HBNC 0.48
  • Revenue
  • STOK $16,742,999.00
  • HBNC $183,718,000.00
  • Revenue This Year
  • STOK $105.42
  • HBNC N/A
  • Revenue Next Year
  • STOK N/A
  • HBNC $13.69
  • P/E Ratio
  • STOK N/A
  • HBNC $32.78
  • Revenue Growth
  • STOK 81.08
  • HBNC N/A
  • 52 Week Low
  • STOK $4.09
  • HBNC $11.18
  • 52 Week High
  • STOK $17.58
  • HBNC $19.18
  • Technical
  • Relative Strength Index (RSI)
  • STOK 36.22
  • HBNC 43.13
  • Support Level
  • STOK $8.42
  • HBNC $15.49
  • Resistance Level
  • STOK $9.77
  • HBNC $16.22
  • Average True Range (ATR)
  • STOK 0.66
  • HBNC 0.44
  • MACD
  • STOK -0.09
  • HBNC 0.04
  • Stochastic Oscillator
  • STOK 28.40
  • HBNC 63.41

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.

About HBNC Horizon Bancorp Inc.

Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.

Share on Social Networks: